Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Citigroup analyst Yigal Nochomovitz downgrades Apellis Pharmaceuticals from Buy to Neutral and lowers the price target from $44 to $41.